Showing 2,481 - 2,500 results of 14,347 for search '(( significantly increased decrease ) OR ( significant ((step decrease) OR (mean decrease)) ))', query time: 0.56s Refine Results
  1. 2481
  2. 2482
  3. 2483
  4. 2484

    Presentation 1_Decreased brain-derived neurotrophic factor expression in chronic kidney disease: integrated clinical and experimental evidence.pptx by Juan Chen (61123)

    Published 2025
    “…</p>Conclusion<p>This study integrated meta-analysis, murine model validation, and single-cell transcriptomic profiling to demonstrate a significant reduction of BDNF in CKD. Furthermore, renal BDNF expression decreased locally, predominantly originating from proximal tubule cells, macrophages, and podocytes, possibly epigenetically inhibited by the upregulation of lnc RNA Bdnf-as.…”
  5. 2485
  6. 2486

    Effect of Viscosol on the expression of inflammatory cytokines, chemokines as well as cell death pathways. by Summan Thahiem (20988319)

    Published 2025
    “…The results shown are represented as mean ±  SD. Significant differences compared to control (****<i>p</i> < 0.0001, ***<i>p</i> < 0.0001, **<i>p</i> < 0.01 and * <i>p</i> <  0.05; two-wayANOVA and Tukey’s test).…”
  7. 2487
  8. 2488
  9. 2489
  10. 2490
  11. 2491
  12. 2492
  13. 2493

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  14. 2494

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  15. 2495

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  16. 2496

    Predictors in ordinal regression model for GDS. by Shane Naidoo (20148021)

    Published 2025
    “…In an ordinal regression model BMI was a significant predictor (<i>B</i> = .10, <i>p</i> = .007) for increases in depression. …”
  17. 2497

    Classification of hand grip strength. by Shane Naidoo (20148021)

    Published 2025
    “…In an ordinal regression model BMI was a significant predictor (<i>B</i> = .10, <i>p</i> = .007) for increases in depression. …”
  18. 2498

    Rating scale for functional severity [28]. by Shane Naidoo (20148021)

    Published 2025
    “…In an ordinal regression model BMI was a significant predictor (<i>B</i> = .10, <i>p</i> = .007) for increases in depression. …”
  19. 2499

    Regression model coefficients. by Shane Naidoo (20148021)

    Published 2025
    “…In an ordinal regression model BMI was a significant predictor (<i>B</i> = .10, <i>p</i> = .007) for increases in depression. …”
  20. 2500

    ICOPE screening positive participant’s responses. by Shane Naidoo (20148021)

    Published 2025
    “…In an ordinal regression model BMI was a significant predictor (<i>B</i> = .10, <i>p</i> = .007) for increases in depression. …”